Suit Challenges FDA's Authority Over Cancer Drugs

A U.S. circuit court is set to hear arguments Thursday on whether terminally ill patients should be allowed access to drugs not approved by the U.S. Food and Drug Administration....

Already a subscriber? Click here to view full article